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Abstract  
Background. Apnoeic oxygenation can come close to matching the oxygen demands of the 
apnoeic patient but does not facilitate carbon dioxide (CO2) elimination, potentially resulting 
in dangerous hypercapnia. Numerous studies have shown that high flow nasal oxygen 
(HFNO) administration prevents hypoxaemia, and appears to reduce the rate of rise of arterial 
CO2 partial pressure (PaCO2), but evidence is lacking to explain these effects. 
Methods. We extended a high-fidelity computational simulation of cardio-pulmonary 
physiology to include modules allowing variable effects of (a) cardiogenic oscillations 
affecting intrathoracic gas spaces, (b) gas-mixing within the anatomical deadspace, (c) 
insufflation into the trachea or above the glottis, and (d) pharyngeal pressure oscillation. We 
validated this model by reproducing the methods and results of five clinical studies on 
apnoeic oxygenation. 
Results. Simulated outputs best matched clinical data for model selection of parameters 
reflecting (a) significant effects of cardiogenic oscillations on alveoli, both in terms of 
strength of the effect (4.5 cmH2O) and percentage of alveoli affected (60%), (b) augmented 
gas-mixing within the anatomical deadspace in HFNO, and (c) pharyngeal pressure 
oscillations between 0 and 2 cmH2O at 70 Hz.  
Conclusion. Cardiac oscillations, deadspace gas-mixing and micro-ventilation induced by 
pharyngeal pressure variations appear to be important mechanisms that combine to facilitate 
clearance of CO2 during apnoea. Evolution of high-flow oxygen-insufflation devices should 
take advantage of these insights, potentially improving apnoeic gas exchange. 
Keywords: Apnoea; Carbon Dioxide; Computer Simulation; Respiratory Physiology. 
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Apnoea is common following induction of anaesthesia and during emergence. 
Accumulation of carbon dioxide (CO2) occurs predictably during apnoea, since CO2 is no 
longer removed from the alveoli to any significant degree once tidal ventilation ceases.1 It has 
been recognized that while apnoeic oxygenation (i.e. mass inflow of oxygen via an open 
airway occurring during apnoea) alone can largely match the oxygen demands of the subject, 
it does not prevent a potentially dangerous rise in the concentration of arterial CO2. Gaseous 
mixing in the anatomical deadspace with generation of low-volume, tidal ventilation through 
cardiogenic volume changes in the alveoli and tracheobronchial airspaces are likely to be 
important physiological mechanisms facilitating gas exchange during apnoea.2-6 Several 
studies 7-9 have shown that nasal cannulae delivering high-flow, humidified oxygen (HFNO) 
can increase apnoea time substantially, by preventing hypoxaemia with only modest rises in 
the arterial partial pressure of carbon dioxide (PaCO2). However, no clear evidence has been 
offered to explain this phenomenon. 
We extended and validated a high-fidelity computational simulator of human cardio-
pulmonary physiology against published data on human apnoea, and used this model to 
conduct an in silico investigation of the mechanisms of transport and exchange of gases and 
the clearance of CO2 during apnoeic oxygenation. Computational simulation offers a fresh 
approach to research into otherwise inaccessible clinical questions and is particularly well 
suited to research in anaesthesia and critical care. Due to the emergency nature of work in 
these clinical specialties, it is difficult to recruit patients to studies examining crisis scenarios; 
it is also difficult to assure appropriate matching, blinding, stratification and control of 
confounders. Furthermore, in silico models of individual subjects and pathologies are 
configurable, reproducible and free of ethical limitations. 
The aim of this study is to investigate the mechanisms of CO2 clearance and exchange of 
gases during apnoeic oxygenation, under the hypothesis that cardiogenic oscillation, gas-
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mixing in the anatomical deadspace and pharyngeal pressure are key physiological 
mechanisms during open-airway apnoea. 
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Methods  
Model description 
Our study used the Interdisciplinary Collaboration in Systems Medicine (ICSM) suite of 
physiological simulations; these comprise highly-integrated computational models of the 
pulmonary and cardiovascular systems, which have been described in detail elsewhere.10-16 
The model has been widely validated and used to investigate apnoea in adults,17-19 
parturients,20, 21 and children.22 
The model includes a series deadspace volume, 100 independently-configurable alveolar 
compartments and 19 in-series cardiovascular compartments. The series deadspace (SD) is 
located between the airway and the alveolar compartments and it is simulated as a series of 
stacked, rigid laminae (𝑁𝑙𝑎𝑚 = 50) of equal volume. The static total volume of the series 
deadspace is set to 150 ml23, 24 (representing a 70-kg adult) and each lamina, 𝑗, has a known 
fraction (𝑓(𝑆𝐷,𝑗)
𝑥 ) of gas 𝑥.  
The pressure of each alveolar compartment is described by a cubic function: 
𝑝𝑖 = ((10 ∙ 𝑣𝑖 − 300)
3/6600) − 𝑃𝑒𝑥𝑡,𝑖  𝑣𝑖 > 0  𝑓𝑜𝑟 𝑖 = 0, … , 𝑁𝑎𝑙𝑣   [1] 
 𝑝𝑖 = 0       𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒  
Equation [1] determines the alveolar pressure 𝑝𝑖 in cmH2O for the 𝑖
𝑡ℎ of 𝑁𝑎𝑙𝑣 alveolar 
compartments for the given volume of alveolar compartment, 𝑣𝑖, in millilitres. 𝑃𝑒𝑥𝑡,𝑖 (per 
alveolar unit, in cmH2O) represents the effective net pressure generated by the sum of the 
effects of factors outside each alveolus.14 
Full details of the model are provided in the Supplementary Data. 
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We recently developed and added four new modules to the existing ICSM suite, 
preliminary validated against an experimental animal study.25 
Cardiogenic oscillations module 
The effect of cardiac oscillations on alveolar compartments was described using the 
following equation: 
𝑃𝑜𝑠𝑐,𝑖 = 𝐾𝑜𝑠𝑐 ∙ 𝜑   for 𝑖 = 0, … , 𝑁𝑜𝑠𝑐  where 𝑁𝑜𝑠𝑐 ≤ 𝑁𝑎𝑙𝑣  [2] 
𝑃𝑜𝑠𝑐,𝑖 represents the pressure generated by the heart, and acting on the alveolar compartment 
𝑖. 𝐾𝑜𝑠𝑐 is a variable parameter representing the strength of the effect of cardiogenic 
oscillations on alveoli, due to the alveoli being compressed by the heart and/or trans-
pulmonary blood volume. 𝑁𝑜𝑠𝑐 is a variable parameter reflecting the number of alveolar 
compartments that are affected by cardiogenic oscillations. The parameter 𝜑 is the ventricular 
activation function, equal to 1 at the peak of systolic contraction and 0 during maximal 
diastolic relaxation.  
Thus, the final equation describing the pressure of each alveolar compartment is:  
𝑝𝑖 = ((10 ∙ 𝑣𝑖 − 300)
3/6600) − 𝑃𝑒𝑥𝑡 − 𝑃𝑜𝑠𝑐,𝑖      [3] 
More detail is presented in the Supplementary Data.  
Anatomical deadspace gas-mixing module 
A variable parameter 𝜎 was added to the calculation of 𝑓(𝑆𝐷,𝑗)
𝑥  representing the proportion of 
gas mixing between adjacent laminae of the series deadspace. The parameter 𝜎 allows for 
varying degrees of mixing between adjacent layers; 𝜎 = 1 indicates complete mixing of 
gases between layers representing the effects of extreme turbulent flow, while 𝜎 = 0 
indicates no mixing of gases.  
Further detail is presented in the Supplementary Data.  
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Tracheal insufflation module 
To reproduce the effects of tracheal gas insufflation (or gas inflow at the top of the series 
deadspace), the flow of gas entering the series deadspace is determined by the variable 
parameters, 𝑟𝑖𝑛𝑠𝑢𝑓𝑓, representing the rate of insufflation in L·min
-1 and 𝑙𝑖𝑛𝑠𝑢𝑓𝑓, representing 
the location of insufflation in different positions across the series deadspace. 
Further detail is presented in the Supplementary Data.  
Pharyngeal pressure 
As a result of high flow through the nasopharynx, we hypothesised an oscillating pressure 
𝑃𝑝ℎ𝑎𝑟  above the glottis. This could be tuned in terms of its frequency and amplitude: 
𝑃𝑝ℎ𝑎𝑟 = 𝐴 ∙ sin (
𝜋
𝑓
)2         (4) 
where, 𝐴 is the amplitude of the pressure in cmH2O and 𝑓is the frequency in Hz. This 
phenomenon can be effectively disabled by setting A to zero. 
Further detail is presented in the Supplementary Data.  
Clinical data used for model calibration and validation  
To calibrate and validate the ICSM simulator with the new modules as a tool for studying 
apnoeic oxygenation, the methods of five previous clinical studies were reproduced 8, 26-29, 
selected for their complete descriptions of subjects (weight, body mass index, functional 
residual capacity, [FRC]), the reproducibility of methods and the detail of results. Approval 
from a research ethics committee was not sought, since the data were obtained from 
previously published literature. The ICSM simulator was set to replicate the mean of the 
patient group described in each study (i.e., using the mean weight and mean FRC) and was 
subjected to the same intervention as the study subjects. Model simulations were run on a 64-
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bit Intel Core i7 3.7 GHz Windows 7 personal computer, running Matlab version R2017a 
MathWorks Inc. MA, USA.  
The studies selected are described below: 
Frumin and co-workers26 studied apnoeic oxygenation in eight healthy men. Patients 
were denitrogenated by breathing 100% oxygen for a minimum of 30 mins (at flow rate of 
oxygen of at least 8 L·min-1). Following the denitrogenation, apnoea persisted for 30-55 min 
with an oxygen flow rate of 200 ml per minute through an endotracheal catheter. Arterial 
blood gases and oxygen saturation during and after apnoeic oxygenation were measured. The 
methodology for the denitrogenation and for the apnoea were reproduced in our model. 
Therefore, the following “population normal” values were assumed in modelling the subject 
group: weight 70 kg, BMI 24 kg·m-2, ventilatory minute volume 420 m1 × 12 min-1, oxygen 
consumption 3.3 mL·kg-1·min-1, FRC 43 mL·kg before the induction of anaesthesia and 20% 
less after the induction of anaesthesia, alveolar dead space 10% of tidal volume and venous 
admixture 1% of cardiac output. 
Fraioli and co-workers27 studied the pulmonary and cardiovascular effects of apnoeic 
oxygenation in man. The authors studied apnoeic oxygenation in 13 patients undergoing 
Jako-laryngoscopy and 18 patients having other minor surgical procedures. After 10 minutes 
of pulmonary denitrogenation with 100% oxygen the apnoeic period was begun via a 
pharyngeal catheter (Jako-laryngoscopy) and endotracheal tube (for patients having minor 
surgical procedure). Arterial blood gases, pH and pulmonary function studies were assessed. 
We replicated the methodology for the patient population having minor surgical procedures. 
The subject group was modelled by using the same “population normal” values used in 
modelling Frumin’s subjects, except for the oxygen consumption and the FRC values that at 
induction of anaesthesia were decreased by 26% and 27%, respectively, as reported in the 
paper.  
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Berthoud and co-workers28 studied six morbidly obese (BMI 49 kg·m-2) and six matched 
non-obese patients (BMI 23.1 kg·m-2) undergoing anaesthesia. Subjects were anesthetized 
after denitrogenation (8 L·min-1 100% oxygen) and were subsequently apnoeic until tracheal 
intubation. The time taken for desaturation of oxyhaemoglobin to 90% during apnoea was 
recorded and arterial blood gases measured. FRC of the subjects was not measured in the 
study, so the ICSM simulator was set up with values for FRC of 43 mL·kg-1 for the non-
obese and 14 mL·kg-1 for the morbidly obese 30 and FRC was assumed to decrease by 20% 
and 50% on induction of anaesthesia in healthy and in obese patients, respectively. 30 The 
minute ventilation before the induction of anaesthesia was configured as 420 mL × 12 min-1 
for the non-obese subjects and 420 mL × 16 min-1 for the obese group. The airway was 
modelled as obstructed after the induction of anaesthesia up to the point of tracheal 
intubation. 
Baraka and co-workers29 investigated the effectiveness of nasopharyngeal oxygen 
insufflation at a rate of 5 L·min-1 in delaying the onset of haemoglobin desaturation during 
the subsequent apnoea in morbidly obese patients (study group: BMI 41.8 kg·m-2) following 
pre-oxygenation using tidal volume breathing for 3 min (10 L min-1 100% oxygen) as 
compared to pre-oxygenation alone (control group: BMI 42.7 kg·m-2). Apnoea was allowed 
to continue until SpO2 fell to 95% or until 4 min had elapsed from the onset of apnoea. The 
time from the onset of apnoea until SpO2 fell to 95% was compared between the two groups. 
The subject group was modelled by using the same values used in modelling Berthoud’s 
subjects. 
Gustafsson and co-workers8 studied apnoeic oxygenation in adults under general 
anaesthesia using HFNO in anesthetized patients. Patients were pre-oxygenated using 40 
L·min-1 100% oxygen, for at least 3 minutes and at the onset of apnoea, the flow of oxygen 
was increased to 70 L·min-1 100% oxygen, and maintained throughout anaesthesia. Arterial 
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blood gases, arterial pH and saturation were recorded. The subject group was modelled by 
using the same values used in modelling Frumin’s subjects. 
Data collection 
In all simulations, the following model outputs were recorded every 5 msec: arterial partial 
pressure of oxygen (PaO2) and CO2 (PaCO2), arterial oxygen saturation (SaO2), arterial pH, 
and cardiac oscillations volume (i.e. tidal volume generated by cardiac oscillations). The 
variable parameters of the new modules of the ICSM simulator were calibrated against 
Frumin’s paper 26 and published values for passive tidal volume generated by cardiac 
oscillations in humans (4–11 ml).31 The parameters were tuned to provide the closest possible 
match between the reported clinical data and the modelled data.  
Data considered from the five clinical investigations were: the rate of rise of PaCO2 and 
arterial pH (Frumin26, Fraioli27, Gustafsson8); PaO2 increase (Fraioli
27), time to reach SaO2 
90% and corresponding PaCO2 (Berthoud
28); time to reach SaO2 95% (Baraka29). All data 
are presented in this manuscript as mean (standard deviation, [SD]). 
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Results 
Parameter-tuning to match previously published data resulted in the cardiogenic 
oscillations module being configured as follows: 𝐾𝑜𝑠𝑐 = 4.5  cm H2O and 𝑁𝑜𝑠𝑐 = 60% 𝑁𝑎𝑙𝑣, 
producing a passive, oscillation-induced, tidal volume of 9 ml during apnoea.31  
In the anatomical deadspace gas-mixing module, the optimal value of the parameter 𝜎 was 
found to be 0.3. Once a satisfactory fit and behaviour of the model was found for this dataset, 
the model was validated against the other 4 studies Fraioli,27 Berthoud,28 Baraka 29 and 
Gustasfsson.8 
For validation of the model against Gustafsson’s study,8 in which the authors did not use 
classical apnoeic oxygenation but rather HFNO, we tuned the parameter (𝜎) from 0.3 to 1. 
Adding a pharyngeal pressure with a frequency of 70 Hz and an amplitude tuned to be 
between 1 and 2 cmH2O
32 achieved an even closer match to the data. 
The complete results of the model validation against the clinical studies,8, 26-29 performed with 
and without the effect of cardiogenic oscillations and gas-mixing in the anatomical 
deadspace, are reported in Table 1.  
Fig. 1 shows the PaCO2 and arterial pH time courses during apnoeic oxygenation when 
recreating the methodology and subject group of Fraioli’s work.27 Enabling the effect of 
cardiac oscillations (𝐾𝑜𝑠𝑐 = 4.5  cmH2O and 𝑁𝑜𝑠𝑐 = 60% 𝑁𝑎𝑙𝑣) and the gas-mixing 
deadspace (𝜎 = 0.3), the model results for the classical apnoeic studies26-29 were within 36% 
of the values found clinically in all cases and within 15% in most cases, and for the HFNO 
study8 results were within 1% (𝐾𝑜𝑠𝑐 = 4.5  cmH2O, 𝑁𝑜𝑠𝑐 = 60% 𝑁𝑎𝑙𝑣 and 𝜎 = 0.6). 
The model results obtained against the data from Gustafsson’s study8 are as follows. In the 
study, the mean apnoea time was 22.5 (4.5) min, SpO2 never reduced below 91%, the rate of 
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increase in PaCO2 was 0.24 (0.05) kPa·min
-1, and arterial pH decreased from 7.44 (0.04) to 
7.14 (0.01). Using the simulator with the effect of cardiac oscillations and the deadspace gas 
mixing, configured as previously, (i.e. 𝐾𝑜𝑠𝑐 = 4.5  cmH2O, 𝑁𝑜𝑠𝑐 = 60% 𝑁𝑎𝑙𝑣 and 𝜎 = 0.3) 
and insufflating 30 L·min-1 at the glottis, the increase in PaCO2 was 0.40 kPa·min
-1, SaO2 
was constant at 99%, and arterial pH decreased from 7.40 to 7.13. By increasing the 
parameter 𝜎 (series deadspace gas mixing) from 0.3 to 1, the rate of rise of PaCO2 was 
reduced to 0.36 kPa·min-1 and arterial pH decreased from 7.40 to 7.15. 
Adding the effect of high frequency pressure variation in the pharynx (above the glottis) with 
an amplitude equal to 1 cmH2O, 𝜎 equal to 1 and glottic insufflation at 30 L·min-1, the rate of 
rise of CO2 fell again to 0.28 kPa·min
-1. Increasing the amplitude to 2 cmH2O, we obtained a 
similar dynamic PaCO2 time course as was presented in the clinical data, with a non-linear 
pattern – an initial rapid increase in PaCO2 that gradually levelled-off during the apnoeic 
period (Fig. 2). The final best fit between the model and the clinical data was achieved by 
setting 𝜎 = 0.6 and 𝑟𝑖𝑛𝑠𝑢𝑓𝑓 = 13 
L·min-1, producing a rate of PaCO2 increase equal to 0.24 
kPa·min-1, and a decrease in arterial pH from 7.40 to 7.22.  
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Discussion 
To our knowledge, the mechanisms underlying gas-mixing during apnoea have so far been 
studied only in animal models.5, 6, 33 We investigated the mechanisms of transport and 
exchange of gases and the clearance of CO2 during apnoea in silico, by configuring a high-
fidelity computational physiological modelling of cardiovascular and pulmonary system 
against five previous studies of apnoea in human subjects. Our results provide strong support 
for the hypothesis that augmented gas-mixing in the anatomical deadspace along with the 
provision of micro-ventilation via cardiogenic oscillations are key physiological mechanisms 
providing clearance of carbon dioxide and oxygenation during open-airway apnoea, and that 
pharyngeal pressure oscillation is an important factor augmenting CO2 clearance during 
HFNO. In all cases, enabling the effects of cardiac oscillation, gas-mixing in deadspace and 
pharyngeal pressure in our model produced model outputs that were closer to the data 
available in clinical studies.  
The ICSM simulation suite was shown to be capable of accurately predicting the results of 
several previous clinical investigations with human subjects. The simulator performed well in 
steady state conditions, but more importantly, also when physiological variables were 
changing quickly. Some deviations between simulator predictions and the clinical results 
were observed, as expected, due to imperfect matching of the modelled subjects to the patient 
group or to unquantified variation in the clinical subjects. For example, Berthoud28 and 
Baraka29 did not measure FRC, but the ICSM simulator required a value for FRC to configure 
study subjects; thus, we used a value of FRC for obese subjects taken from another study.30  
Our study allowed the separation of the contributing physiological mechanisms involved in 
apnoea in order to study the behaviour of each mechanism individually. By integrating 
cardiac oscillations, anatomical deadspace gas-mixing modules and oxygen insufflation 
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into/above the trachea into our model, we could evaluate different degrees of mixing between 
adjacent layers in the series deadspace on clearance of CO2 and a range of flow rates of 
oxygen on ventilation and oxygenation during apnoea. For the validation of the model against 
Gustafsson’s study,8 in which the authors used high-flow nasal oxygen, we initially found a 
rate of rise of PaCO2 equal to 0.40 kPa·min
-1 using the configuration of parameters used for 
the other four studies. Subsequent adjustment of model parameters governing gas-mixing in 
the series deadspace and glottic oxygen-insufflation rate allowed us to reduce this value 
closer to that found clinically; further addition of high-frequency glottic pressure variation 
(soft tissue “wobble”) brought the model predictions very close to those found clinically, 
lending support to the hypothesis that such mechanisms are important, and informing our 
understanding of their relative strengths and importance.  
Thus, during classical apnoeic oxygenation (without HFNO) the physiological mechanisms 
for the clearance of CO2 are represented by a combination of relatively small amount of gas-
mixing in the anatomical deadspace and generation of ventilation through cardiac 
oscillations; it is not possible to determine which factor has the greatest importance. During 
open-airway apnoea with HFNO, the combination of cardiac oscillations together with a high 
degree of gas-mixing in the anatomical deadspace and with the high-frequency glottic 
pressure appear to be the physiological mechanisms for CO2 clearance, and the most 
important contribution is provided by high-frequency pressure oscillation in the pharynx. 
Future evolution of high-flow, upper-airway, oxygen-insufflation devices could take 
advantage of the mechanisms proposed here, since it is likely that gas-exchange facilitated by 
high-flow nasal cannulae is achieved via a combination of the mechanisms proposed in this 
manuscript noting that potentially only a fraction of the total delivered gas reaches the 
trachea. The new additions that we have made to the ICSM simulator could also assist with 
the development of apnoeic oxygenation devices, such as THRIVE,8 in different clinical 
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scenarios, such as term pregnancy, severe lung disease and rapid sequence induction.  
Limitations of the study include the possibility that subjects were not modelled exactly, e.g. 
not considering fully the effect of muscle relaxants. However, the modelling of the subjects 
was performed before the recreation of the methodologies, and was thus blinded. Although 
we have validated the model against published data, future work will focus on collection and 
incorporation of new clinical data to further evolve the detail and veracity of the simulation 
suite, allowing us to investigate the effect of pathological conditions that may modify the 
dynamics of apnoea. 
  
16 
 
Authors’ contributions  
Design of initial model: JGH  
New module development: ML, AD, JGH, DGB 
Validation of the model: ML, JGH, DGB, AD 
Interpretation of results. ML, AD, MC, DGB, JGH 
Writing and final approval of manuscript: ML, AD, MC, DGB, JGH 
Acknowledgements  
The authors thank Fisher and Paykel (New Zealand) for sponsorship of research into apnoea 
and mechanisms of gas exchange during high-flow nasal oxygenation. 
Declaration of Interest 
None declared. 
Supplementary Data 
Supplementary Data are available online. 
  
17 
 
References  
1 McCahon RA, Hardman JG. Fighting for breath: apnoea vs the anaesthetist. Anaesthesia 
2007; 62: 105-8 
2 Cybulsky IJ, Abel JG, Menon AS, Salerno TA, Lichtenstein SV, Slutsky AS. Contribution 
of cardiogenic oscillations to gas exchange in constant-flow ventilation. J Appl Physiol 1987; 
63: 564-70 
3 Slutsky AS, Watson J, Leith DE, Brown R. Tracheal insufflation of O2 (TRIO) at low flow 
rates sustains life for several hours. Anesthesiology 1985; 63: 278-86 
4 Slutsky AS. Gas mixing by cardiogenic oscillations: a theoretical quantitative analysis. J 
Appl Physiol 1981; 51: 1287-93 
5 Watson JW, Burwen DR, Kamm RD, Brown R, Slutsky AS. Effect of Flow Rate on Blood 
Gases during Constant Flow Ventilation in Dogs. Am Rev Respir Dis 1986; 133: 626-9 
6 Watson J, Kamm RD, Burwen DR, Brown R, Ingenito E, SWTSKY AS. Gas Exchange 
during Constant Flow Ventilation with Different Gases1-3. Am Rev Respir Dis 1987; 136: 
420-5 
7 Patel A, Nouraei SA. Transnasal Humidified Rapid‐Insufflation Ventilatory Exchange 
(THRIVE): a physiological method of increasing apnoea time in patients with difficult 
airways. Anaesthesia 2015; 70: 323-9 
8 Gustafsson I-M, Lodenius Å, Tunelli J, Ullman J, Jonsson Fagerlund M. Apnoeic 
oxygenation in adults under general anaesthesia using Transnasal Humidified Rapid-
Insufflation Ventilatory Exchange (THRIVE)–a physiological study. Br J Anaesth 2017; 118: 
610-7 
18 
 
9 Lyons C, Callaghan M. Apnoeic oxygenation with high‐flow nasal oxygen for laryngeal 
surgery: a case series. Anaesthesia 2017; 72: 1379-87 
10 Hardman JG, Bedforth NM, Ahmed AB, Mahajan RP, Aitkenhead AR. A physiology 
simulator: validation of its respiratory components and its ability to predict the patient's 
response to changes in mechanical ventilation. Br J Anaesth 1998; 81: 327-32 
11 Bedforth NM, Hardman JG. Predicting patients' responses to changes in mechanical 
ventilation: a comparison between physicians and a physiological simulator. Intens Care Med 
Exp 1999; 25: 839-42 
12 Hardman JG, Bedforth NM. Estimating venous admixture using a physiological simulator. 
Br J Anaesth 1999; 82: 346-9 
13 Das A, Haque M, Chikhani M, et al. Development of an integrated model of 
cardiovascular and pulmonary physiology for the evaluation of mechanical ventilation 
strategies. Conf Proc IEEE Eng Med Biol Soc 5319-22 
14 Chikhani M, Das A, Haque M, Wang W, Bates DG, Hardman JG. High PEEP in acute 
respiratory distress syndrome: quantitative evaluation between improved oxygenation and 
decreased oxygen delivery. Br J Anaesth 2016; 117: 9 
15 Das A, Gao Z, Menon PP, Hardman JG, Bates DG. A systems engineering approach to 
validation of a pulmonary physiology simulator for clinical applications. J R Soc Interface 
2011; 8: 44-55 
16 Das A, Menon PP, Hardman JG, Bates DG. Optimization of mechanical ventilator settings 
for pulmonary disease states. IEEE Transactions on Biomedical Engineering 2013; 60: 1599-
607 
17 Hardman JG, Wills JS, Aitkenhead AR. Investigating hypoxemia during apnea: validation 
of a set of physiological models. Anesth Analg 2000; 90: 614-8 
19 
 
18 McNamara MJ, Hardman JG. Hypoxaemia during open‐airway apnoea: a computational 
modelling analysis. Anaesthesia 2005; 60: 741-6 
19 Hardman JG, Aitkenhead AR. Validation of an original mathematical model of CO2 
elimination and dead space ventilation. Anesth Analg 2003; 97: 1840-5 
20 McClelland SH, Bogod DG, Hardman JG. Pre‐oxygenation in pregnancy: an investigation 
using physiological modelling. Anaesthesia 2008; 63: 259-63 
21 McClelland SH, Bogod DG, Hardman JG. Pre‐oxygenation and apnoea in pregnancy: 
changes during labour and with obstetric morbidity in a computational simulation. 
Anaesthesia 2009; 64: 371-7 
22 Hardman JG, Wills JS. The development of hypoxaemia during apnoea in children: a 
computational modelling investigation. Br J Anaesth 2006; 97: 564-70 
23 West JB. Ventilation in Respiratory Physiology - The Essential. Philadelphia: Wolters 
Kluwer Health/Lippincott Williams & Wilkins, 2012; 1-11 
24 Lumb AB. Distribution of Pulmonary Ventilation and Perfusion in Nunn's Applied 
Respiratory Physiology. Edinburgh; New York: Elsevier, 2017; 109-35 
25 Laviola M, Das A, Chikhani M, Bates D, Hardman JG. Investigating the effect of cardiac 
oscillations and deadspace gas mixing during apnea using computer simulation. Conf Proc 
IEEE Eng Med Biol Soc 2017: 337-40 
26 Frumin J, Epstein RM, Cohen G. Apneic oxygenation in man. Anesthesiology 1959; 20: 
789-98 
27 Fraioli RL, Sheffer LA, Steffenson JL. Pulmonary and Cardiovascular Effects of Apneic 
Oxygenation in Man. Anesthesiology 1973; 39: 588-96 
20 
 
28 Berthoud MC, Peacock JE, Reilly CS. Effectiveness of preoxygenation in morbidly obese 
patients. Br J Anaesth 1991; 67: 464-6 
29 Baraka AS, Taha SK, Siddik‐Sayyid SM, et al. Supplementation of pre‐oxygenation in 
morbidly obese patients using nasopharyngeal oxygen insufflation. Anaesthesia 2007; 62: 
769-73 
30 Damia G, Mascheroni D, Croci M, Tarenzi L. Perioperative changes in functional residual 
capacity in morbidly obese patients. Br J Anaesth 1988; 60: 574-8 
31 Colebatch HJH, Ng CKY, Maccioni FJ. Inspiratory gas flow induced by cardiac systole. 
Resp Physiol 1996; 105: 103-8 
32 Parke RL, Bloch A, McGuinness SP. Effect of Very-High-Flow Nasal Therapy on Airway 
Pressure and End-Expiratory Lung Impedance in Healthy Volunteers. Resp Care 2015; 60: 
1397-403 
33 Mackenzie CF, Skacel M, Barnas GM, Brampton WJ, Alana CA. Effects of cardiac 
oscillations and lung volume on acinar gas mixing during apnea. J Appl Physiol 1990; 68: 
2013-8 
21 
 
Table  
Table 1. Validation of the model against the five clinical studies with and without the effect of cardiac 
oscillations and gas-mixing deadspace. 
  
Clinical Data 
 
Model 
       
  Cardiac Oscillations ON ON OFF OFF 
  Gas mixing ON OFF ON OFF 
Frumin26       
Rate of rise PaCO2  
(kPa·min-1) 
0.40 (0.07)  0.40 0.95 0.98 0.98 
Minimum level of  
arterial pH 
6.72  7.08 6.88 6.87 6.87 
Fraioli27       
Rate of rise PaCO2  
(kPa·min-1) 
0.43 (0.04)  0.50 0.84 0.84 0.84 
PaO2 increase  
(%) 
30.1 (24)  26.4 47.8 47.7 47.9 
Arterial pH decrease  
(min-1) 
0.02 (0.00)  0.02 0.02 0.02 0.02 
Berthoud34       
Time to SaO2=90% obese  
(s) 
196 (80)  184 181 181 181 
PaCO2 at SaO2=90% obese 
(kPa) 
6.20 (1.1)  6.79 6.79 6.79 6.79 
Time to SaO2=90% non-obese 
(s) 
595 (142)  500 495 495 493 
Baraka34       
Time to SaO2=95% study 
 (s) 
240 (0)  240 240 240 240 
Time to SaO2=95% control (s) 145 (27)  187 206 190 206 
Gustafsson8       
Rate of rise PaCO2  
(kPa·min-1) 
0.24 (0.05)  0.24 0.90 0.54 0.91 
Arterial pH decrease 
(min-1) 
0.06 (0.00)  0.01 0.02 0.01 0.02 
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Cardiogenic Oscillations: ON the effect of cardiac oscillations is enabled (𝐾𝑜𝑠𝑐 = 4.5 cmH2O and 𝑁𝑜𝑠𝑐 = 60% 𝑁𝑎𝑙𝑣); OFF 
the effect of cardiac oscillations is disabled 𝐾𝑜𝑠𝑐 = 0 cmH2O and 𝑁𝑜𝑠𝑐 = 0% 𝑁𝑎𝑙𝑣;  
Gas Mixing: ON effect of gas mixing is enabled (𝜎 = 0.3 for the studies of Frumin, Fraioli, Berthoud, and Baraka and 𝜎 =
0.6 for Gustafsson’s study); OFF the effect of gas mixing is disabled (𝜎 = 0).  
For the results of model validation against Gustassfon’s study, the pharyngeal pressure is set to 2 cmH2O and the rate of 
oxygen insufflation is equal to 13 L min-1.  
Results from the clinical studies are presented as mean (SD). 
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Figure legends 
Fig. 1 
Time-course of PaCO2 (black) and arterial pH (pink) for the output model (straight line) and 
the clinical investigation of Fraioli’s study27 (dots). The grey dashed line indicates the 
beginning of apnoea after pre-oxygenation. 
Fig. 2 
Time-course of PaCO2 (black) and arterial pH (pink) for the output model (straight line) and 
the clinical investigation of Gustafsson and co-workers8 (dots). The grey dashed line 
indicates the beginning of apnoea after pre-oxygenation. 


